|
Synonyms: Example 2 [WO2020156271]
Compound class:
Synthetic organic
Comment: Embricitinib is the INN for a Janus kinase inhibitor with anti-inflammatory and immunosuppressant potential. The chemical structure was obtained from WHO INN Proposed List 135 (July 2026). The same chemical structure is claimed in patent WO2020156271 (Jiangsu Vcare Pharmatech) [1]. The company pipeline declares a single orally bioavailable JAK1 inhibitor named VC005, so this is likely the same as embricitinib.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||